Cargando…
FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical Outcomes
The genomic basis of cutaneous T-cell lymphoma has been characterized by gene copy number alterations and genomic sequencing, but there are few clinical tests that are being widely used to inform the diagnosis and prognosis of leukemic cutaneous T-cell lymphoma that may arise as a progression from m...
Autores principales: | Avery, Jonathan, Kim, Sa Rang, Cheng, Wei, Foss, Francine, Girardi, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477749/ https://www.ncbi.nlm.nih.gov/pubmed/37674691 http://dx.doi.org/10.1016/j.xjidi.2023.100212 |
Ejemplares similares
-
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
por: Kim, Sa Rang, et al.
Publicado: (2018) -
A rare presentation of cutaneous T-cell lymphoma mimicking morphea
por: Yu, Beverly, et al.
Publicado: (2023) -
B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma
por: King, Amber Loren O., et al.
Publicado: (2020) -
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma
por: Lansigan, Frederick, et al.
Publicado: (2010) -
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic
por: Zic, John A., et al.
Publicado: (2020)